Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stephens Investment Management Group (SIMG) is a specialized investment management firm that focuses on small- and mid-cap growth equities, with a significant emphasis on the healthcare, biotechnology, and life sciences sectors. Founded in 2005 and headquartered in Houston and Little Rock, the firm operates as a subsidiary of Stephens Investments Holdings. SIMG employs a research-intensive approach to identify companies with transformative catalysts and durable growth, often investing in innovative biotech, medical device, and healthcare service providers. The firm is part of the broader Stephens financial network, which includes a prominent healthcare investment banking division that advises on M&A and capital raising for life science companies. SIMG manages several billion dollars in assets and maintains a portfolio that includes significant positions in established growth leaders within the pharmaceutical and medical technology industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stephens Investment Management.